Copayment level and medication adherence in type 2 diabetes patients managed with insulin aspart pen therapy

被引：1
|
作者：
Lee, W. C.
Balu, S.
Cobden, D.
Joshi, A., V
Pashos, C. L.
机构：
[1] Abt Associates Inc, Bethesda, MD USA
[2] Abt Associates Inc, Lexington, MA USA
[3] Novo Nordisk Inc, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68730-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A63 / A63
页数：1
相关论文
共 50 条
  • [21] Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes
    Lindholm, A
    Jensen, LB
    Home, PD
    Raskin, P
    Boehm, BO
    Råstam, J
    DIABETES CARE, 2002, 25 (05) : 876 - 882
  • [22] Insulin Aspart in pediatric patients with type I diabetes
    Tsalikian, E
    Mueller, PG
    PEDIATRIC RESEARCH, 2000, 47 (04) : 140A - 140A
  • [23] Cost-effectiveness of pharmacist managed medication therapy adherence clinic (MTAC) on type 2 diabetes patients in a Tertiary Hospital in Malaysia
    Loganadan, Navin K.
    Lim, Kah Y.
    Nur, Noorulashikin Mohd
    Ariffin, Fudziah
    PHARMACOTHERAPY, 2012, 32 (10): : E270 - E270
  • [24] Comparison of biphasic insulin aspart and human insulin premix in patients with Type 2 diabetes
    Itoh, Hiroshi
    Morikawa, Akizuki
    Asai, Mahito
    Nishimura, Hideo
    Atoh, Keita
    Mutou, Eiji
    Oshima, Eiji
    Iwashima, Yasunor-I
    Miura, Takanori
    Sekiguchi, Masatomo
    Tani, Mitsunori
    Haneda, Masakazu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S65 - S65
  • [25] Insulin aspart in adolescent patients with type 1 diabetes
    Tsalikian, E
    Silverstein, J
    Mueller, PG
    DIABETES, 2000, 49 : A127 - A128
  • [26] Impact of patient education on glycemic control, medication knowledge level and medication adherence of patients with type 2 diabetes
    Apikoglu-Rabus, Sule
    Sero, Meltem
    Okuyan, Betul
    Izzettin, Fikret V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 264 - 265
  • [27] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
    Saiyarsarai, P.
    Khosroshahi, Ghazizadeh A.
    Khedmati, J.
    Ghaffari, S.
    Soleymani, F.
    Seyyedifar, M.
    VALUE IN HEALTH, 2019, 22 : S576 - S576
  • [28] Copayment Level and Drug Switching: Findings for Type 2 Diabetes
    Saito, Erin P.
    Davis, James W.
    Harrigan, Rosanne C.
    Juarez, Debora
    Mau, Marjorie K.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2010, 2 (07) : 412 - 420
  • [29] CLINICAL IMPACT OF INITIATING INSULIN GLARGINE THERAPY WITH DISPOSABLE PEN VERSUS VIAL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN A MANAGED CARE SETTING
    Davis, Stephen N.
    Wei, Wenhui
    Garg, Satish
    ENDOCRINE PRACTICE, 2011, 17 (06) : 845 - 852
  • [30] Assessing the adherence to insulin therapy and the effect of injection pain on insulin adherence among type 2 diabetes mellitus patients
    Mikhael, Ehab Mudher
    Al-Rubaye, Mohammed Hayder
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2020, 11 (01) : 65 - 68
12345